CAS 54193-28-1
:Doxorubicinol
Description:
Doxorubicinol, with the CAS number 54193-28-1, is a metabolite of the anthracycline antibiotic doxorubicin, which is widely used in cancer therapy. This compound retains some of the pharmacological properties of its parent drug, including antitumor activity, but has a different profile in terms of efficacy and toxicity. Doxorubicinol is characterized by its ability to intercalate DNA, disrupting the replication process and leading to cell death, which is a common mechanism of action among anthracyclines. It is typically less potent than doxorubicin but can contribute to the overall therapeutic effects in patients undergoing treatment. The compound is also known for its potential cardiotoxicity, a side effect associated with doxorubicin, although the extent may vary. In terms of physical properties, doxorubicinol is a red-orange crystalline solid, soluble in water and organic solvents, which facilitates its formulation for clinical use. Its chemical structure includes a tetracyclic ring system, characteristic of anthracyclines, contributing to its biological activity.
Formula:C27H31NO11
InChI:InChI=1S/C27H31NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15-17,22,29-31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,16-,17-,22+,27-/m0/s1
InChI key:InChIKey=NKZRZOVSJNSBFR-FEMMEMONSA-N
SMILES:OC=1C2=C([C@@H](O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C[C@@]([C@H](CO)O)(O)C2)C(O)=C4C1C(=O)C=5C(C4=O)=C(OC)C=CC5
Synonyms:- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1,2-dihydroxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, [8S-[8α,8(R*),10α]]-
- 13-Dihydrodoxorubicin
- 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S,10S)-
- (8S,10S)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-[(1S)-1,2-dihydroxyethyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione
- Adriamycinol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 6 products.
Doxorubicinol hydrochloride
CAS:Formula:C27H32ClNO11Purity:≥ 90.0% (sum of isomers)Color and Shape:Red to dark red/brown powderMolecular weight:582.0Doxorubicinol
CAS:<p>Doxorubicinol is the major circulating metabolite of doxorubicin with antineoplastic acitivity.</p>Formula:C27H31NO11Color and Shape:SolidMolecular weight:545.54Doxorubicinol Hydrochloride (>90%)(Mixture of diastereomers)
CAS:Controlled Product<p>Applications A metabolite of Doxorubicin as neoplasm inhibitor.<br>References Smith, T.H.<br></p>Formula:C27H31NO11•HClColor and Shape:RedMolecular weight:545.54 + 36.46Doxorubicinol (>90%)
CAS:Controlled Product<p>Applications Doxorubicinol is a cardiotoxic metabolite of Doxorubicin (D558000). Used as an antineoplastic.<br>References Freeland, M.M., et. al.: Anti-Cancer Drug, 23, 584 (2012)<br></p>Formula:C27H31NO11Purity:>90%Color and Shape:NeatMolecular weight:545.54Doxorubicinol,mixture of diastereomers
CAS:<p>Doxorubicinol, a mixture of diastereomers, is an anthracycline antibiotic that inhibits the growth of cells by binding to DNA and preventing the production of RNA. Doxorubicinol has been shown to be effective in treating breast cancer and solid tumours, including those resistant to doxorubicin. This drug has also been shown to inhibit the production of matrix metalloproteinases that are involved in tumor invasion and metastasis. The concentration-time curve for doxorubicinol can be determined experimentally by blood sampling and measuring its metabolites. The ryanodine receptor is a calcium channel found on the surface membrane of cardiac muscle cells that regulates intracellular calcium levels. Doxorubicinol may bind to this receptor, which could account for its cardiotoxic effects.</p>Formula:C27H31NO11Purity:(%) Min. 90%Molecular weight:545.54 g/mol




